
Chlorpheniramine Maleate (2mg) + Paracetamol (500mg) + Phenylephrine (10mg)
Active composition
+2 more active ingredients
Chlorpheniramine Maleate antagonizes H1 receptors, preventing the action of histamine and reducing allergy symptoms.
Paracetamol works by inhibiting cyclooxygenase (COX) enzymes, leading to reduced synthesis of prostaglandins in the brain, which are responsible for pain and fever.
Phenylephrine activates alpha-adrenergic receptors, leading to vasoconstriction and reduced blood flow to nasal mucosa, thereby decreasing swelling and congestion.
Medical applications
LCZ Plus New Tablet is a combination medication containing Chlorpheniramine Maleate (2mg), Paracetamol (500mg), and Phenylephrine (10mg), formulated to provide effective relief from symptoms associated with common cold, allergic rhinitis, and sinusitis. Chlorpheniramine Maleate, an antihistamine, helps alleviate allergic symptoms such as sneezing, runny nose, and watery eyes by blocking histamine H1 receptors. Paracetamol acts as an analgesic and antipyretic, reducing fever and relieving mild to moderate pain including headaches, muscle aches, and sore throat commonly experienced during upper respiratory tract infections. Phenylephrine, a selective alpha-1 adrenergic receptor agonist, serves as a decongestant by constricting nasal blood vessels, thereby reducing nasal congestion and improving nasal airflow. The combined action of these active ingredients makes LCZ Plus New Tablet suitable for symptomatic management of cold and allergy-related conditions. It is important to use this medication as directed by a healthcare professional and to be cautious in patients with hypertension, cardiovascular diseases, or thyroid disorders due to the vasoconstrictive effects of Phenylephrine. LCZ Plus New Tablet should be avoided in individuals with known hypersensitivity to any component of the formulation. Proper dosage adherence and consultation with a physician are recommended to ensure safety and efficacy.
How to use LCZ Plus New Tablet Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. LCZ Plus New Tablet may be taken with or without food, but it is better to take it at a fixed time.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
It is unsafe to consume alcohol with LCZ Plus New Tablet.
High Risk
LCZ Plus New Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Exercise Caution
LCZ Plus New Tablet should be used with caution in patients with liver disease. Dose adjustment of LCZ Plus New Tablet may be needed. Please consult your doctor.
Regular Checkup
LCZ Plus New Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Consult Doctor
LCZ Plus New Tablet is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of LCZ Plus New Tablet may not be needed in these patients. Please consult your doctor. Use of LCZ Plus New Tablet may cause excessive sleepiness in patients with end stage kidney disease.
Regular Checkup
0 reviews for LCZ Plus New Tablet

Chlorpheniramine Maleate (2mg) + Paracetamol (500mg) + Phenylephrine (10mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+2 more active ingredients
Chlorpheniramine Maleate antagonizes H1 receptors, preventing the action of histamine and reducing allergy symptoms.
Paracetamol works by inhibiting cyclooxygenase (COX) enzymes, leading to reduced synthesis of prostaglandins in the brain, which are responsible for pain and fever.
Phenylephrine activates alpha-adrenergic receptors, leading to vasoconstriction and reduced blood flow to nasal mucosa, thereby decreasing swelling and congestion.
Medical applications
LCZ Plus New Tablet is a combination medication containing Chlorpheniramine Maleate (2mg), Paracetamol (500mg), and Phenylephrine (10mg), formulated to provide effective relief from symptoms associated with common cold, allergic rhinitis, and sinusitis. Chlorpheniramine Maleate, an antihistamine, helps alleviate allergic symptoms such as sneezing, runny nose, and watery eyes by blocking histamine H1 receptors. Paracetamol acts as an analgesic and antipyretic, reducing fever and relieving mild to moderate pain including headaches, muscle aches, and sore throat commonly experienced during upper respiratory tract infections. Phenylephrine, a selective alpha-1 adrenergic receptor agonist, serves as a decongestant by constricting nasal blood vessels, thereby reducing nasal congestion and improving nasal airflow. The combined action of these active ingredients makes LCZ Plus New Tablet suitable for symptomatic management of cold and allergy-related conditions. It is important to use this medication as directed by a healthcare professional and to be cautious in patients with hypertension, cardiovascular diseases, or thyroid disorders due to the vasoconstrictive effects of Phenylephrine. LCZ Plus New Tablet should be avoided in individuals with known hypersensitivity to any component of the formulation. Proper dosage adherence and consultation with a physician are recommended to ensure safety and efficacy.
How to use LCZ Plus New Tablet Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. LCZ Plus New Tablet may be taken with or without food, but it is better to take it at a fixed time.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
It is unsafe to consume alcohol with LCZ Plus New Tablet.
High Risk
LCZ Plus New Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Exercise Caution
LCZ Plus New Tablet should be used with caution in patients with liver disease. Dose adjustment of LCZ Plus New Tablet may be needed. Please consult your doctor.
Regular Checkup
LCZ Plus New Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Consult Doctor
LCZ Plus New Tablet is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of LCZ Plus New Tablet may not be needed in these patients. Please consult your doctor. Use of LCZ Plus New Tablet may cause excessive sleepiness in patients with end stage kidney disease.
Regular Checkup
0 reviews for LCZ Plus New Tablet















